| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income including noncontrolling interest | 1,524,700 | 935,000 | 406,500 | 1,652,400 |
| Depreciation | 493,800 | 327,900 | 161,200 | 473,700 |
| Amortization | 226,500 | 149,900 | 74,900 | 226,200 |
| Deferred income taxes | -57,100 | -60,700 | -21,000 | -149,700 |
| Share-based compensation expense | 109,500 | 75,900 | 42,200 | 109,500 |
| Pension and postretirement plan contributions | 67,100 | 29,000 | 15,600 | 43,700 |
| Pension and postretirement plan expense (income), net | 10,400 | 6,900 | 3,400 | 11,500 |
| Restructuring charges, net of cash paid | -12,500 | 5,400 | 21,800 | -11,700 |
| Sale of global surgical solutions business | -1,100 | -1,100 | -1,100 | 382,700 |
| Other, net | -20,400 | -6,800 | 4,400 | -17,700 |
| Accounts receivable | 150,300 | 122,400 | 9,100 | 109,300 |
| Inventories | 37,600 | 76,900 | 69,100 | 163,600 |
| Other assets | -34,100 | -22,300 | 29,900 | 41,100 |
| Accounts payable | -47,800 | 7,400 | -2,500 | 277,700 |
| Other liabilities | -185,600 | -178,400 | -190,100 | 180,300 |
| Cash provided by operating activities | 1,862,500 | 1,071,200 | 369,400 | 2,047,200 |
| Capital expenditures | 716,200 | 454,600 | 237,900 | 634,800 |
| Property and other assets sold | 46,400 | 42,400 | 21,600 | 3,300 |
| Acquisitions and investments in affiliates, net of cash acquired | 500 | 500 | - | 56,400 |
| Divestiture of businesses, net of cash divested | -14,900 | -14,900 | -14,900 | 889,700 |
| Other, net | 43,800 | 20,800 | -7,200 | 8,100 |
| Cash (used for) provided by investing activities | -729,000 | -448,400 | -224,000 | 193,700 |
| Net issuances of commercial paper and notes payable | 1,100 | -800 | 4,500 | 3,300 |
| Long-term debt borrowings | 1,019,000 | 500,000 | - | - |
| Long-term debt repayments | 674,200 | - | - | 630,400 |
| Reacquired shares | 374,600 | 199,200 | 153,700 | 983,700 |
| Dividends paid | 564,400 | 380,000 | 192,000 | 502,900 |
| Exercise of employee stock options | 182,000 | 139,000 | 98,500 | 232,800 |
| Hedge settlements | - | - | - | 600 |
| Other, net | -10,600 | -3,300 | 1,100 | -2,500 |
| Cash used for financing activities | -421,700 | 55,700 | -241,600 | -1,884,000 |
| Effect of exchange rate changes on cash and cash equivalents | -12,800 | -14,400 | 2,000 | -15,300 |
| Increase in cash and cash equivalents | 699,000 | 664,100 | -94,200 | 341,600 |
| Cash and cash equivalents at beginning of period | 1,256,800 | 1,256,800 | 1,256,800 | 919,500 |
| Cash and cash equivalents at end of period | 1,955,800 | 1,920,900 | 1,162,600 | 1,261,100 |
ECOLAB INC. (ECL)
ECOLAB INC. (ECL)